Capital International Investors
HCAT icon

Capital International Investors’s Health Catalyst HCAT Stock Holding History

Capital International Investors’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-495,377
Closed -$23.2M – 459
2021
Q1 		$23.2M Sell
495,377
-840,360
-63% -$40.7M 0.01% 382
2020
Q4 		$58.1M Hold
1,335,737
– – 0.02% 319
2020
Q3 		$48.9M Buy
1,335,737
+111,937
+9% +$3.8M 0.02% 320
2020
Q2 		$35.7M Buy
1,223,800
+531,100
+77% +$14.7M 0.01% 322
2020
Q1 		$18.1M Buy
692,700
+292,700
+73% +$8.94M 0.01% 323
2019
Q4 		$13.9M Hold
400,000
– – ﹤0.01% 339
2019
Q3 		$12.7M Buy
+400,000
New +$15.7M ﹤0.01% 349

Other funds holding HCAT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Capital International Investors's HCAT Position: Q2 2021 in Review

Capital International Investors sold out of Health Catalyst (HCAT) in Q2 2021, closing a stake of 495,377 shares — an estimated $23.2M sold.

Capital International Investors first reported a position in HCAT in Q3 2019 and held it in 7 quarters. The position peaked at $58.1M in Q4 2020. 198 funds tracked by Wall St. Rank hold HCAT as of Q2 2021.

  • Capital International Investors reported no remaining Health Catalyst position as of Q2 2021 after selling out during the quarter.
  • Capital International Investors sold 495,377 Health Catalyst shares in Q2 2021, an estimated $23.2M.
  • Capital International Investors first reported a position in Health Catalyst in Q3 2019 and held it in 7 quarters.
  • Capital International Investors's Health Catalyst position peaked at $58.1M in Q4 2020.
  • 198 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2021.

Based on Capital International Investors's 13F filing for Q2 2021, filed 16 Aug 2021.